New 'Ready-Made' cell therapy tested for tough blood cancers
NCT ID NCT04416984
Summary
This study is testing a new type of cell therapy called ALLO-501A for adults with large B-cell lymphoma or CLL/SLL that has come back or hasn't responded to other treatments. The goal is to see if this 'off-the-shelf' therapy, made from donor cells instead of the patient's own, is safe and can help control the cancer. Researchers will also test a companion drug, ALLO-647, given before the cell therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advent Health
Orlando, Florida, 06510, United States
-
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212, United States
-
Augusta University
Augusta, Georgia, 30912, United States
-
Avera Medical
Sioux Falls, South Dakota, 57117, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
CHU de Québec -Université Laval; Hôpital de l'Enfant-Jésus
Québec, Quebec, G1J 1Z4, Canada
-
City of Hope
Duarte, California, 91010, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218-1234, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
MD Anderson Cancer Center - University of Texas
Houston, Texas, 77030, United States
-
Mayo Clinic Hospital
Phoenix, Arizona, 85054, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612-9416, United States
-
Monash Medical Centre
Clayton, Victoria, 3168, Australia
-
Northside Hospital - Atlanta
Atlanta, Georgia, 30342, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40207, United States
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
QEII Health Sciences Centre-VG Site
Halifax, Nova Scotia, B3H 2Y9, Canada
-
St. David's South Austin Medical Center
Austin, Texas, 78704, United States
-
St. Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065, Australia
-
Stanford Cancer Institute
Palo Alto, California, 94035, United States
-
Texas Oncology
Dallas, Texas, 75251, United States
-
UCLA Medical Center
Los Angeles, California, 90095, United States
-
University of Miami
Miami, Florida, 33136, United States
-
Vanderbilt Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
Yale School of Medicine
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.